Kartogenin (KGN) --- Chondrogenesis Modulator


Catalog No. size PriceQuantity
M60027-2D 10 mM in DMSO (0.631 mL) $79
M60027-2S 2mg solid $79
M60027-10S 10mg solid $316

Description

Kartogenin (KGN) is a potent small molecule that can promote chondrocyte differentiation of human mesenchymal stem cells/MSCs (EC50 = 100 nM). It was identified by an imaging-based high throughput screening in human MSCs. KGN also shows chondro-protective effects in vitro, and is efficacious in collagenase and surgery induced OA models in mice. MOA studies suggested that KGN binds to filamin A, disrupts its interaction with the transcription factor CBFβ, and induces chondrogenesis by regulating the CBFβ-RUNX1 transcriptional program. Kartogenin serves as a very useful tool to study and promote chondrogenesis, and may provide a new strategy of cell-based therapy for treating osteoarthritis.

Product information

CAS Number: 4727-31-5

Molecular Weight: 317.34

Formula: C20H15NO3

Chemical Name: 2-([1,1'-biphenyl]-4-ylcarbamoyl)benzoic acid

Smiles: OC(=O)C1=CC=CC=C1C(=O)NC1C=CC(=CC=1)C1C=CC=CC=1

InChiKey: SLUINPGXGFUMLL-UHFFFAOYSA-N

InChi: InChI=1S/C20H15NO3/c22-19(17-8-4-5-9-18(17)20(23)24)21-16-12-10-15(11-13-16)14-6-2-1-3-7-14/h1-13H,(H,21,22)(H,23,24)

Technical Data

Appearance: Solid Power.

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: DMSO up to 50 mM

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined.

HS Tariff Code: 382200

How to use

In Vitro:

Kartogenin was used at 5-10 µM concentration in primary human bone marrow MSCs. It was also used in an assay where primary bovine articular chondrocytes and cartilage explants were grown in the presence of TNF-a and oncostatin M to mimic cytokine-induced damage during OA pathogenesis.

In Vivo:

10 µM KGN in 4 µl of saline was intra-articularly (IA) delivered into mice on days 7 and 21 in the collagenase VII–induced model and the acute surgical model.

References:

  1. Kristen Johnson, et al. A Stem Cell–Based Approach to Cartilage Repair. 2012; Science. 336(6082):717-21

Products are for research use only. Not for human use.


Documents

Payment & Security

American Express Diners Club Discover JCB Mastercard PayPal Venmo Visa

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Estimate shipping

You may also like

Recently viewed